| 000 | 01037 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516141548.0 | ||
| 264 | 0 | _c20131216 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1875-6212 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Backer, Daniel | |
| 245 | 0 | 0 |
_aClinical management of the cardiovascular failure in sepsis. _h[electronic resource] |
| 260 |
_bCurrent vascular pharmacology _cMar 2013 |
||
| 300 |
_a222-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomyopathies _xdrug therapy |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOxygen Consumption _xphysiology |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aSepsis _xcomplications |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aScolletta, Sabino | |
| 773 | 0 |
_tCurrent vascular pharmacology _gvol. 11 _gno. 2 _gp. 222-42 |
|
| 999 |
_c22593391 _d22593391 |
||